Home > Boards > US Listed > Biotechs > Allergan (AGN)

AGN post-mortem: #msg-108366179.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 728
Posts 110,031
Boards Moderated 16
Alias Born 09/05/02
160x600 placeholder
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/13/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 12/13/2019 9:51:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/12/2019 10:50:00 AM
Form 8.3 -AbbVie Inc Dow Jones News - 12/12/2019 10:05:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/11/2019 10:50:00 AM
Form 8.3 - [Abbvie. Inc.] Dow Jones News - 12/11/2019 9:32:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/10/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 12/10/2019 9:50:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/9/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 12/9/2019 9:50:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/6/2019 10:50:00 AM
Form 8.3 - [ AbbVie Inc.] Dow Jones News - 12/6/2019 9:46:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/5/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 12/5/2019 9:37:00 AM
Allergan Announces Positive Phase 3 ACHIEVE I Trial Results for Ubrogepant Published in The New England Journal of Medicine PR Newswire (US) - 12/4/2019 5:26:00 PM
Form 8.3 - Abbvie Inc Dow Jones News - 12/4/2019 9:52:00 AM
Form 8.3 - Abbvie Inc Dow Jones News - 12/3/2019 10:36:00 AM
Form 8.3 - [ AbbVie Inc.] Dow Jones News - 12/2/2019 9:56:00 AM
Announcement under the Irish Takeover Rules: Relevant Securities in Issue - November 29, 2019 PR Newswire (US) - 11/29/2019 2:00:00 PM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/29/2019 10:04:00 AM
Form 8.3 - [Abbvie. Plc] Dow Jones News - 11/29/2019 10:00:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 11/28/2019 10:50:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 11/28/2019 9:30:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 11/28/2019 9:25:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 11/27/2019 10:50:00 AM
DewDiligence Member Level  Thursday, 11/20/14 12:15:08 PM
Re: DewDiligence post# 98
Post # of 103 
AGN post-mortem: #msg-108366179.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist